Evidence map›Paper›PMID 40873389›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025

Intracellular and Extracellular Vesicle miRNA Signatures in Human iPSC-Derived Neural Stem Cells and Floor Plate Progenitors.

Lilian Cruz, Frederico Moraes Ferreira, Camila Miranda Lopes-Ramos, Zhiyun Wei, William T Hendriks, H A Jinnah, Helder I Nakaya, D Cristopher Bragg, Anna M Krichevsky, Xandra Owens Breakefield and 1 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Intracellular and Extracellular Vesicle miRNA Signatures in Human iPSC-Derived Neural Stem Cells and Floor Plate Progenitors.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lilian CruzDepartment of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Frederico Moraes FerreiraCellular, Genetic, and Molecular Nephrology Laboratory (LIM-29), Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil.
Camila Miranda Lopes-RamosDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Zhiyun WeiDepartment of Neurology, Brigham and Women's Hospital and Harvard Medical School, HMS Initiative for RNA Medicine, Boston, Massachusetts, USA.
William T HendriksDepartment of Neurology, Massachusetts General Hospital and Program in Neuroscience, Harvard Medical School, Charlestown, Massachusetts, USA.
H A JinnahDepartment of Neurology, Emory University, Atlanta, Georgia, USA.
Helder I NakayaDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
D Cristopher BraggDepartment of Neurology, Massachusetts General Hospital and Program in Neuroscience, Harvard Medical School, Charlestown, Massachusetts, USA.
Anna M KrichevskyDepartment of Neurology, Brigham and Women's Hospital and Harvard Medical School, HMS Initiative for RNA Medicine, Boston, Massachusetts, USA.
Xandra Owens BreakefieldDepartment of Neurology, Massachusetts General Hospital and Program in Neuroscience, Harvard Medical School, Charlestown, Massachusetts, USA.
Marilene Hohmuth LopesDepartment of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KAHN, BARBARA B. · 2000 to 2019
$31.4M
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASEST32HL007427 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI DAWN L DEMEO, Edwin K Silverman · 1985 to 2026
$13.6M
Unraveling the Complexities of Risk and Mechanism in CancerR35CA220523 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI QUACKENBUSH, JOHN · 2018 to 2024
$6.0M
P&F programP30DK135043 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Aaron S Leong · 2023 to 2026
$5.4M
Human Induced Pluripotent Stem Cells As Models for Inherited Developmental DisordersR56NS102980 · NINDS · EMORY UNIVERSITY · PI JINNAH, HYDER A · 2017 to 2017
$546k
A Zeiss LSM800 confocal microscope with AiryscanS10OD021577 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 2016 to 2016
$374k
American Lung Association (ALA) LCD-821824Boston Area Diabetes Endocrinology Research Center (BADERC) DK057521Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 307677/2022‑2Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 406258/2022‑8Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 409941/2021‑2Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) 001FAPESP 2018/14933-2Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2011/13906-2Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2013/22078-1Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2015/25756-6Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2018/15557-4Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) FAPESP2018/14933-2HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NIH R56 NS102980HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) P01NS08799NCI NIH HHS R35 CA220523NHLBI NIH HHS T32 HL007427NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30 DK057521NIDDK NIH HHS P30 DK135043NIH HHS S10 OD021577NINDS NIH HHS R56 NS102980Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai (IBD Center) DK043351
6 · The paper itself

Abstract

Refined control of intrinsic and extrinsic signals is critical for specific neuronal differentiation. Here, we differentiated human induced pluripotent stem cells (hiPSCs) from three different healthy donors into neural stem cells (NSCs) and floor plate progenitors (FPPs; progenitors of dopaminergic neurons) and further performed intracellular and extracellular vesicles' (EVs) miRNA profiling. While NSC and FPP cells differed significantly in levels of only 8 intracellular miRNAs, their differences were more evident in the EV miRNAs with 27 differentially expressed miRNAs. Target validation of intracellular miRNAs revealed that FPPs expressed more EXOC5 mRNA than NSCs, which is implicated in the function of primary cilia, an essential signaling organelle in FPPs. Moreover, we found a group of 5 miRNAs consistently enriched in EVs from these three cell types. This study presents a foundation for the field of miRNA regulation in neural development and provides new insights for disease modeling and regenerative medicine.

Indexed as

Extracellular VesiclesInduced Pluripotent Stem CellsMicroRNAsNeural Stem CellsCell DifferentiationCells, CulturedDopaminergic NeuronsHumansMicroRNAsdopaminergic neuronsEXOC5exosomesfloor plate progenitorshuman induced pluripotent stem cellsmicroRNAneural differentiationneuronal development

Identifiers

PMID40873389
PMCPMC12392061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.